endpoint launches ConnectionPOINT ™, a collaboration program designed to achieve accelerated results and advance medicine by interconnecting next-generation eClinical technologies. EClinical Technologies
PR Newswire
SAN FRANCISCO, April 21, 2021
SAN FRANCISCO, April 21, 2021 / PRNewswire / – endpoint Clinical, the world’s leading interactive response technology (IRT®) company, today announced the launch of its collaborative program ConnectionPOINT ™, the first of its kind in the field of eClinical technology. The vision of the program is to achieve a guided convergence of a selected network of eClinical providers, who are leaders in innovation in their fields and dedicated to promoting the transition to a smarter next-generation interface.
“Although this is our official launch of a collaborative program, we have worked with the best eClinic technology providers to help transform the future of drug development for more than a decade,” said Ryan Keane, Director of Final Operations. “What we have learned from the commitment to build relationships and build technology for so long is that together we can see further to drive the industry forward and also have the real ability to meet and then overcome. these common goals. ConnectionPOINT is the result. This gives sponsors peace of mind that systems that are traditionally disparate from multiple eClinical providers can not only communicate seamlessly with each other, but also push the boundaries with data speeds and efficiencies that are nowhere to be found. the current eClinic ecosystem “.
ConnectionPOINT’s core mission is to encourage a sustainable and scalable infrastructure between a network of strong and proven alliances that support eClinic business and technology, based on the principles of creating opportunities, driving innovation and harmonizing ecosystem service delivery.
One of the most attractive applications for these strategic alliances is to strengthen the alignment between technology and service lines that are often considered independent, essential on their own and with common historical intersections, but which are now ready to generate disruptive new opportunities. Here’s what some of the endpoint partners have to say about ConnectionPOINT’s already recognized benefits and achievements through their existing technology that interfaces with IRT endpoints:
“When TSS and endpoint came together to explore what our companies could accomplish together in our field, we instantly realized that it was possible to accomplish more than the easy accomplishments of old contact points, such as monitoring. basic transportation, ”he commented. Evan Hahn, Vice President for North America for TSS, a leading global provider of temperature monitoring technologies and services. “All conversations at all levels between the endpoint and TSS, from CEOs to technical SMEs and business development, quickly echo the idea of how far we can go and prepare this part of the ecosystem for changes in industry and the sea. need to share real-time data and functionality around temperature monitoring. It was clear that the end point and the TSS would quickly gather the expected practical basis of an integrated approach. The next step would be to move forward with the next generation of dual track time integration that works beyond the item-level shipping level, applies to central stock as well as standard transportation needs and is ready to operate across all borders where technology Wireless monitoring opens this space. Exactly what I did. the straight line to a goal does not happen without both organizations is very aligned. “
“One of the direct data collection (DDC) options in encapsia®, eSource DDC, is an important opportunity for industry as an independent alternative, but its main benefit is to bring simplicity to the complex ecosystem of clinical trial technologies and services. To this end, more than two and a half years ago we capitalized on the dynamic architecture of encapsulation with the approach of the endpoint of hyperintegration in a joint effort to closely connect systems in a spectrum of expertise for both schools and managers. of study. ”Said Temitope Keyes, CEO of Cmed Technology.“ Encapsulation and endpoint teams have demonstrated a deep commitment to partnership, customer success, technological innovation and industry-leading leadership, driving our mutual ability to deliver a very comprehensive set of systems. harmonized with We provide an intuitive and efficient solution for clinical supplies and workflows for clinical operations, always compliant and using dynamic data in near real time. ”
The spectrum of possibilities can range from deep product interconnection to new business models and requires all of the above.
“The tools and systems built by our industry are often very protocol-specific and driven by the needs of sponsors. As a result, plants often come with countless learning applications as well as login credentials. Managing and retaining partners,” said Rick Malone , executive director for business development at McCreadie Group. “We are looking for solutions that give drug research teams the flexibility to complete their preferred workflow tasks, while meeting the specific needs of sponsors for each protocol. We are excited to work with a similar partner. sees the merger of the Center and the needs of sponsors through our pioneering integration as a win-win for all involved.The McCreadie Group and Final Team spent over a year developing a solution that would make life easier for the Centers, while providing greater speed and integrity. of sponsor data. “
“As much as it is a promise to capitalize on the collective experience, strengths and obvious benefits of direct interaction between partners, we recognize that it also creates a challenge for those who join this team,” said Vincent Puglia, CEO of Partnerships Final Strategies. “Interact constantly, deepen conversations, break down barriers, consider new business models and tirelessly ask” what’s next? “And what else can we do?” “It’s a significant commitment. It won’t be for everyone, but for those who take on a mission like ConnectionPOINT, the quality of the results can’t be underestimated.”
More information
Visit our website to find out more about the Endpoint ConnectionPOINT program.
Connect with the endpoint on LinkedIn
About the end point
endpoint is a provider of interactive response technology (IRT®) systems and solutions specializing in the life sciences industry. Over the last decade, its team of customer-oriented professionals has continuously developed its suite of technologies to help sponsors achieve good results in their clinical trials. PULSE®, your dynamic IRT solution for randomizing and managing the delivery of patients, plants and medicines and DRIVE, the innovative clinical supply management tool, have proven to optimize the supply chain and minimize operating costs, thus managing over time useful and accurate the patient’s medication is guaranteed. Endpoint is headquartered in San Francisco, California, along with other offices in the United States, the European Union and Asia. www.endpointclinical.com
Contact:Catherine Ditzler Associate Marketing Director Endpoint Clinical 1-415-688-3424 Email: [email protected]
Photo: https://mma.prnewswire.com/media/1492520/endpoint_Clinical_Launches_ConnectionPOINT.jpg
Final clinical source